These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 29553114

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.
    Cicardi M, Banerji A, Bracho F, Malbrán A, Rosenkranz B, Riedl M, Bork K, Lumry W, Aberer W, Bier H, Bas M, Greve J, Hoffmann TK, Farkas H, Reshef A, Ritchie B, Yang W, Grabbe J, Kivity S, Kreuz W, Levy RJ, Luger T, Obtulowicz K, Schmid-Grendelmeier P, Bull C, Sitkauskiene B, Smith WB, Toubi E, Werner S, Anné S, Björkander J, Bouillet L, Cillari E, Hurewitz D, Jacobson KW, Katelaris CH, Maurer M, Merk H, Bernstein JA, Feighery C, Floccard B, Gleich G, Hébert J, Kaatz M, Keith P, Kirkpatrick CH, Langton D, Martin L, Pichler C, Resnick D, Wombolt D, Fernández Romero DS, Zanichelli A, Arcoleo F, Knolle J, Kravec I, Dong L, Zimmermann J, Rosen K, Fan WT.
    N Engl J Med; 2010 Aug 05; 363(6):532-41. PubMed ID: 20818888
    [Abstract] [Full Text] [Related]

  • 23. Icatibant in hereditary angioedema: news and challenges.
    Bouillet L.
    Expert Rev Clin Immunol; 2011 May 05; 7(3):267-72. PubMed ID: 21595592
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Population Pharmacokinetics and Exposure-Response Analyses to Guide Dosing of Icatibant in Pediatric Patients With Hereditary Angioedema.
    Wang Y, Jomphe C, Marier JF, Martin P.
    J Clin Pharmacol; 2021 Apr 05; 61(4):555-564. PubMed ID: 33091166
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema.
    Piras V, Alves F, Gonçalo M.
    Dermatol Ther; 2019 Nov 05; 32(6):e13098. PubMed ID: 31579975
    [Abstract] [Full Text] [Related]

  • 32. Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.
    Maurer M, Aberer W, Bouillet L, Caballero T, Fabien V, Kanny G, Kaplan A, Longhurst H, Zanichelli A, I O S Investigators.
    PLoS One; 2013 Nov 05; 8(2):e53773. PubMed ID: 23390491
    [Abstract] [Full Text] [Related]

  • 33. Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study.
    Grumach AS, Henriques MT, Bardou MLD, Pontarolli DA, Botha J, Correa M, IOS Brazil Study Group.
    An Bras Dermatol; 2022 Nov 05; 97(4):448-457. PubMed ID: 35654647
    [Abstract] [Full Text] [Related]

  • 34. Icatibant.
    Deeks ED.
    Drugs; 2010 Nov 05; 70(1):73-81. PubMed ID: 20030426
    [Abstract] [Full Text] [Related]

  • 35. Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey.
    Longhurst HJ, Aberer W, Bouillet L, Caballero T, Fabien V, Zanichelli A, Maurer M, IOS Investigators.
    Allergy Asthma Proc; 2015 Nov 05; 36(5):399-406. PubMed ID: 26314822
    [Abstract] [Full Text] [Related]

  • 36. Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.
    Greve J, Hoffmann TK, Schuler P, Lang S, Chaker A, Bas M.
    Int J Dermatol; 2011 Oct 05; 50(10):1294-5. PubMed ID: 21950301
    [Abstract] [Full Text] [Related]

  • 37. First report of icatibant treatment in a pregnant patient with hereditary angioedema.
    Farkas H, Kőhalmi KV, Veszeli N, Tóth F, Varga L.
    J Obstet Gynaecol Res; 2016 Aug 05; 42(8):1026-8. PubMed ID: 27093898
    [Abstract] [Full Text] [Related]

  • 38. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
    Bas M, Greve J, Stelter K, Bier H, Stark T, Hoffmann TK, Kojda G.
    Ann Emerg Med; 2010 Sep 05; 56(3):278-82. PubMed ID: 20447725
    [Abstract] [Full Text] [Related]

  • 39. Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
    Krause K, Metz M, Zuberbier T, Maurer M, Magerl M.
    J Dtsch Dermatol Ges; 2010 Apr 05; 8(4):272-4. PubMed ID: 19758369
    [Abstract] [Full Text] [Related]

  • 40. Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years.
    Farkas H, Kőhalmi KV.
    Expert Rev Clin Immunol; 2018 Jun 05; 14(6):447-460. PubMed ID: 29757016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.